| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 12/13/2006 | EP1730286A2 Therapeutic anti-cancer dna |
| 12/13/2006 | EP1730285A1 Transgenic mice inducing alzheimer's disease expressing mutant betactf99 |
| 12/13/2006 | EP1730284A2 Self-processing plants and plant parts |
| 12/13/2006 | EP1730283A1 Method for improving plants |
| 12/13/2006 | EP1730282A1 Glycosylation variants of ricin-like proteins |
| 12/13/2006 | EP1730281A2 Immunostimulatory nucleic acids for inducing il-10 responses |
| 12/13/2006 | EP1730280A2 Rna interference modulators of hedgehog signaling and uses thereof |
| 12/13/2006 | EP1730279A2 Epha4 as therapeutic target of prc and pdaca |
| 12/13/2006 | EP1730278A1 Method for preparation and purification of recombinant proteins |
| 12/13/2006 | EP1730277A2 Ligational encoding using building block oligonucleotides |
| 12/13/2006 | EP1730276A1 Method, chip, device and system for extraction of biological materials |
| 12/13/2006 | EP1730275A1 Lactobacillus fermentum n-desoxyribosyl transferases and the use thereof for enzymatic synthesis of 2', 3' -didesoxynucleosides and 2',3'-didehydro-2', 3'-didesoxynucleosides |
| 12/13/2006 | EP1730274A1 Novel modified s-hydroxynitrile lyase |
| 12/13/2006 | EP1730273A1 Method and apparatus of automatically isolating and purifying nucleic acid |
| 12/13/2006 | EP1730271A2 Enzyme and preparation method |
| 12/13/2006 | EP1730198A2 Adzymes and uses thereof |
| 12/13/2006 | EP1730191A2 Immunoglobulins |
| 12/13/2006 | EP1730185A1 Cancer associated antigens |
| 12/13/2006 | EP1730184A2 Improved interleukin-2 muteins |
| 12/13/2006 | EP1730180A1 Antifungal peptides |
| 12/13/2006 | EP1730178A2 Novel antibiotic alternatives |
| 12/13/2006 | EP1730173A2 Nucleic acid molecules encoding novel murine low-voltage activated calcium channel proteins, designated-alpha 1h, encoded proteins and methods of use thereof |
| 12/13/2006 | EP1730171A1 Peptide mimotopes of mycobacterial mannosylated lipoglycans and uses thereof |
| 12/13/2006 | EP1730162A2 Artificial mutation controls for diagnostic testing |
| 12/13/2006 | EP1729816A2 Transcription factor rna interference reagents and methods of use thereof |
| 12/13/2006 | EP1729806A2 Human anthrax toxin neutralizing monoclonal antibodies and methods of use thereof |
| 12/13/2006 | EP1729795A2 Albumin fusion proteins |
| 12/13/2006 | EP1729787A1 Method of proliferating precursor cells |
| 12/13/2006 | EP1729780A2 Methods for protein production |
| 12/13/2006 | EP1729580A2 Methods for controlling plant pathogens using n-phosphonomethylglycine |
| 12/13/2006 | EP1729570A1 Ion channel |
| 12/13/2006 | EP1729569A1 TRANSGENIC MODEL FOR ALZHEIMER’S DISEASE |
| 12/13/2006 | EP1615670A4 Targets for tumor growth inhibition |
| 12/13/2006 | EP1546403A4 Actn3 genotype screen for athletic performance |
| 12/13/2006 | EP1534836B1 Mutant forms of meningococcal adp-ribosylating toxin |
| 12/13/2006 | EP1490507B1 Method for the identification of microorganisms by means of in situ hybridization and flow cytometry |
| 12/13/2006 | EP1488001A4 Methods for generating double stranded dna comprising a 3' single stranded portion and uses of these complexes for recombination |
| 12/13/2006 | EP1487966B1 Secretion of proteins with multiple disulfide bonds in bacteria and uses thereof |
| 12/13/2006 | EP1482975B1 Prevention of tissue adhesion |
| 12/13/2006 | EP1440079B1 Acyclic linker-containing oligonucleotides and uses thereof |
| 12/13/2006 | EP1436408A4 A method for identifying effector molecules for gene network integration |
| 12/13/2006 | EP1421200B1 Fluorescent multiplex hpv pcr assays using multiple fluorophores |
| 12/13/2006 | EP1373530B1 Protein kinase stress-related protein and methods of use in plants |
| 12/13/2006 | EP1358350B1 Polynucleotide sequence assay |
| 12/13/2006 | EP1354204B1 Hcv antigen/antibody combination assay |
| 12/13/2006 | EP1343896B1 Small acid-soluble spore protein and uses thereof |
| 12/13/2006 | EP1338651B1 Method of screening remedy for diabetes |
| 12/13/2006 | EP1291427B1 Method of detecting and quantifying human p450 molecular species and probe and kit for this method |
| 12/13/2006 | EP1290201B1 Recombinant subunit proteins from porcine parvovirus produced in plants |
| 12/13/2006 | EP1287133B1 Regulation of human dopamine-like g protein-coupled receptor |
| 12/13/2006 | EP1268836B1 Non-human sperm-dna complexes for genetically modifying non-human animals |
| 12/13/2006 | EP1268808B1 Mutants of lactobacillus casei defective in carbon catabolism regulation |
| 12/13/2006 | EP1261712B1 Proteins named fctrx and nucleic acids encoding same |
| 12/13/2006 | EP1229114B1 Gene encoding protein capable of regenerating luciferin, novel recombinant dna and process for producing protein capable of regenerating luciferin |
| 12/13/2006 | EP1206554B1 Activatable recombinant neurotoxins |
| 12/13/2006 | EP1197143B1 Goodpasture's syndrome model mouse |
| 12/13/2006 | EP1179067B1 Neuroprotective properties of gdf-15, a member of the tgf-beta superfamily |
| 12/13/2006 | EP1171615B1 Cell culture process for glycoproteins |
| 12/13/2006 | EP1171605B1 Peptides and assays for the diagnosis of lyme disease and compositions useful for the prevention thereof |
| 12/13/2006 | EP1147208B1 Compositions and methods for intraductal gene therapy |
| 12/13/2006 | EP1124961B1 Thrombopoietic compounds |
| 12/13/2006 | EP1123979B1 Process for producing coenzyme q10 |
| 12/13/2006 | EP1123392B1 Prv-1 gene and the use thereof |
| 12/13/2006 | EP1121441B1 Selectively replicating viral vectors |
| 12/13/2006 | EP1117803B1 Method for the production of (poly)peptides by using truncated variants of the sv40 large t antigen with an intact n terminus |
| 12/13/2006 | EP1117795B1 Tgf-beta superfamily mutant members, including morphogenic proteins |
| 12/13/2006 | EP1108786B1 Novel collectin |
| 12/13/2006 | EP1108041B1 Transgenic amorpha-4,11-diene synthesis |
| 12/13/2006 | EP1078078B1 Complex formed by a peptide and a major histocompatibility complex at the surface of phages |
| 12/13/2006 | EP1024836B1 Compositions for delivering genes to antigen presenting cells of the skin |
| 12/13/2006 | EP1021550B1 Use of beta recombinase in eukaryotic cells, especially for transgenic work |
| 12/13/2006 | EP1007969A4 Lithographic mask design and synthesis of diverse probes on a substrate |
| 12/13/2006 | EP0981600B1 Transformed microorganisms with improved properties |
| 12/13/2006 | EP0980429B1 Human toll-like receptor proteins, related reagents and methods |
| 12/13/2006 | EP0979276B1 Complement receptor type 1 (cr1)-like sequences |
| 12/13/2006 | EP0973914B1 Proteins having lecithin-cholesterol acyltransferase-like activity, their production and use |
| 12/13/2006 | EP0968284B1 An improved method for the production and purification of adenoviral vectors |
| 12/13/2006 | EP0927043B1 Compositions for gene transfer to the central nervous system |
| 12/13/2006 | EP0854885B1 Recombinant anti-cd4 antibodies for human therapy |
| 12/13/2006 | EP0809695B1 Transcription factor - e2f-5 |
| 12/13/2006 | EP0792375B9 Enzymatic dna molecules |
| 12/13/2006 | EP0760602B1 Use of fas ligand to suppress lymphocyte-mediated immune responses |
| 12/13/2006 | EP0651805B1 Method of intracellular binding of target molecules |
| 12/13/2006 | CN1878871A IL-1 receptor based antagonists and methods of making and using |
| 12/13/2006 | CN1878870A Method of posttranslational modification by adding mycrosomal membrane in cell-free protein synthesis |
| 12/13/2006 | CN1878869A Method of posttranslational modification by adding mycrosomal membrane in cell-free protein synthesis |
| 12/13/2006 | CN1878867A Recombinant peptide vector comprising the gene for treatment for autoimmune diseases |
| 12/13/2006 | CN1878866A Methods and compositions for preparing RNA from a fixed sample |
| 12/13/2006 | CN1878865A Cell-free notch cleavage analysis method and drug screening method |
| 12/13/2006 | CN1878864A Insulin-expressing human islet cell lines capable of reversibly proliferating and use thereof |
| 12/13/2006 | CN1878863A Method and apparatus for concentration and purification of nucleic acid |
| 12/13/2006 | CN1878859A Novel brevibacillus choshinensis and process for producing protein with use of the microbe as host |
| 12/13/2006 | CN1878789A Human cathelicidin antimicrobial peptides |
| 12/13/2006 | CN1878785A Delta12 desaturases suitable for altering levels of polyunsaturated fatty acids in oleaginous yeast |
| 12/13/2006 | CN1878784A Motoneuronotrophic factor gene sequences |
| 12/13/2006 | CN1878566A Multi-antigen vectors of melanoma |
| 12/13/2006 | CN1878463A Method of producing sterile plant, plant obtained by using the same and use thereof |
| 12/13/2006 | CN1876843A Method of detecting variation or polymorphism |
| 12/13/2006 | CN1876834A Hybridization detecting unit and DNA chip including the detecting unit |
| 12/13/2006 | CN1876820A Purification method adapted to mass production of plasmid DNA |